日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Enhancing the therapeutic index of [(211)At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands

利用碘化物假载体提高[(211)At]YF2的治疗指数：一种减少其在肾脏、唾液腺和泪腺中蓄积的简便策略

期刊:Nuclear Medicine and Biology
影响因子:3
doi:10.1016/j.nucmedbio.2025.109028
Huynh, Truc T; Feng, Yutian; Banks, Rebecca L; Vaidyanathan, Ganesan; Zalutsky, Michael R
发表日期：2025
文献求助 收藏

A third generation PSMA-targeted agent [(211)At]YF2: Synthesis and in vivo evaluation

第三代PSMA靶向药物[(211)At]YF2：合成及体内评价

期刊:Nuclear Medicine and Biology
影响因子:3
doi:10.1016/j.nucmedbio.2024.108916
Feng, Yutian; Meshaw, Rebecca L; Finch, Sean W; Zheng, Yongxiang; Minn, Il; Vaidyanathan, Ganesan; Pomper, Martin G; Zalutsky, Michael R
发表日期：2024
文献求助 收藏

Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases

低剂量全脑放射治疗可增强单域抗体片段对人表皮生长因子受体2型（HER2）阳性脑转移瘤的诊疗潜力

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdac135
Procissi, Daniele; Jannetti, Stephen A; Zannikou, Markella; Zhou, Zhengyuan; McDougald, Darryl; Kanojia, Deepak; Zhang, Hui; Burdett, Kirsten; Vaidyanathan, Ganesan; Zalutsky, Michael R; Balyasnikova, Irina V
信号转导
HER2
神经科学
发表日期：2022
文献求助 收藏

An Improved (211)At-Labeled Agent for PSMA-Targeted α-Therapy

一种改进的（211）At标记的PSMA靶向α疗法药物

期刊:
影响因子:
doi:10.2967/jnumed.121.262098
Mease, Ronnie C; Kang, Choong Mo; Kumar, Vivek; Banerjee, Sangeeta Ray; Minn, Il; Brummet, Mary; Gabrielson, Kathleen L; Feng, Yutian; Park, Andrew; Kiess, Ana P; Sgouros, George; Vaidyanathan, Ganesan; Zalutsky, Michael R; Pomper, Martin G
发表日期：2022
文献求助 收藏

Gold Nanostars: A Novel Platform for Developing (211)At-Labeled Agents for Targeted Alpha-Particle Therapy

金纳米星：一种用于开发靶向α粒子治疗的(211)At标记剂的新型平台

期刊:International Journal of Nanomedicine
影响因子:6.5
doi:10.2147/IJN.S327577
Liu, Yang; Zhou, Zhengyuan; Feng, Yutian; Zhao, Xiao-Guang; Vaidyanathan, Ganesan; Zalutsky, Michael R; Vo-Dinh, Tuan
发表日期：2021
文献求助 收藏

Synthesis and preliminary evaluation of (211)At-labeled inhibitors of prostate-specific membrane antigen for targeted alpha particle therapy of prostate cancer

合成并初步评价(211)At标记的前列腺特异性膜抗原抑制剂在前列腺癌靶向α粒子治疗中的应用

期刊:Nuclear Medicine and Biology
影响因子:3
doi:10.1016/j.nucmedbio.2021.01.002
Vaidyanathan, Ganesan; Mease, Ronnie C; Minn, Il; Choi, Jaeyeon; Chen, Ying; Shallal, Hassan; Kang, Choong Mo; McDougald, Darryl; Kumar, Vivek; Pomper, Martin G; Zalutsky, Michael R
肿瘤
前列腺癌
肿瘤免疫
发表日期：2021
文献求助 收藏

Site-Specific and Residualizing Linker for (18)F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment

用于 (18)F 标记并增强肾清除率的位点特异性和残留连接子：应用于抗 HER2 单域抗体片段

期刊:
影响因子:
doi:10.2967/jnumed.120.261446
Zhou, Zhengyuan; Meshaw, Rebecca; Zalutsky, Michael R; Vaidyanathan, Ganesan
HER2
发表日期：2021
文献求助 收藏

Labeling Monoclonal Antibody with α-emitting (211)At at High Activity Levels via a Tin Precursor

通过锡前体以高活性水平标记α发射(211)At单克隆抗体

期刊:Cancer Biotherapy and Radiopharmaceuticals
影响因子:2.1
doi:10.1089/cbr.2019.3204
Vaidyanathan, Ganesan; Pozzi, Oscar R; Choi, Jaeyeon; Zhao, Xiao-Guang; Murphy, Shawn; Zalutsky, Michael R
单克隆抗体
发表日期：2020
文献求助 收藏

Observations on the Effects of Residualization and Dehalogenation on the Utility of N-Succinimidyl Ester Acylation Agents for Radioiodination of the Internalizing Antibody Trastuzumab

关于残留化和脱卤化对N-琥珀酰亚胺酯酰化剂用于内化抗体曲妥珠单抗放射性碘化应用效果的影响的观察

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules24213907
Chitneni, Satish K; Koumarianou, Eftychia; Vaidyanathan, Ganesan; Zalutsky, Michael R
发表日期：2019
文献求助 收藏

Labeling Single Domain Antibody Fragments with Fluorine-18 Using 2,3,5,6-Tetrafluorophenyl 6-[(18)F]Fluoronicotinate Resulting in High Tumor-to-Kidney Ratios

利用 2,3,5,6-四氟苯基 6-[(18)F]氟烟酸酯对单域抗体片段进行氟-18 标记，可获得较高的肿瘤/肾脏比率

期刊:Molecular Pharmaceutics
影响因子:4.5
doi:10.1021/acs.molpharmaceut.8b00951
Zhou, Zhengyuan; McDougald, Darryl; Devoogdt, Nick; Zalutsky, Michael R; Vaidyanathan, Ganesan
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏